We are happy to continue with ODSC Interview series. 

In this Lightning Interview from ODSC and Ai+ Training,  Daphne Koller, CEO and Founder of insitro, will share her knowledge about and expertise in machine learning-drive drug discovery. She'll discuss the challenges faced, recent advances, and what she believes is the future of this technology and it's role in the healthcare and Pharma industries.

This talk was livestreamed on all official ODSC social media - Linkedin, Facebook, Twitter, Youtube etc.

Local ODSC chapter in NYC, USA

Instructor's Bio

Daphne Koller

CEO and Founder of insitro | Co-Founder of Engageli

Daphne is CEO and Founder of insitro, a machine learning-driven drug discovery and development company. She is also co-founder of Engageli, was the Rajeev Motwani Professor of Computer Science at Stanford University, where she served on the faculty for 18 years, the co-CEO and President of Coursera, and the Chief Computing Officer of Calico Labs. She is the author of over 300 refereed publications with an h-index of 146. Daphne was recognized as one of TIME Magazine’s 100 most influential people in 2012. She received the MacArthur Foundation Fellowship in 2004, the ACM Prize in Computing in 2008, the ACM AAAI Allen Newell Award in 2019, and the Technical Leadership Abie Award Winner in 2022. She was inducted into the National Academy of Engineering in 2011 and elected a fellow of the American Association for Artificial Intelligence in 2004, the American Academy of Arts and Sciences in 2014, and the International Society of Computational Biology in 2017.


  • 1

    ON-DEMAND WEBINAR: Lightning Interview: "AI Enabled Drug Discovery"

    • Ai+ Training

    • Webinar recording